Hormonal status in protracted critical illness and in-hospital mortality

Tarek Sharshar, Sylvie Bastuji-Garin, Andrea Polito, Bernard De Jonghe, Robert D. Stevens, Virginie Maxime, Pablo Rodriguez, Charles Cerf, Hervé Outin, Philippe Touraine, Kathleen Laborde

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Introduction: The aim of this study was to determine the relationship between hormonal status and mortality in patients with protracted critical illness.Methods: We conducted a prospective observational study in four medical and surgical intensive care units (ICUs). ICU patients who regained consciousness after 7 days of mechanical ventilation were included. Plasma levels of insulin-like growth factor 1 (IGF-1), prolactin, thyroid-stimulating hormone, follicle-stimulating hormone, luteinizing hormone, estradiol, progesterone, testosterone, dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS) and cortisol were measured on the first day patients were awake and cooperative (day 1). Mean blood glucose from admission to day 1 was calculated.Results: We studied 102 patients: 65 men and 37 women (29 of the women were postmenopausal). Twenty-four patients (24%) died in the hospital. The IGF-1 levels were higher and the cortisol levels were lower in survivors. Mean blood glucose was lower in women who survived, and DHEA and DHEAS were higher in men who survived.Conclusions: These results suggest that, on the basis of sex, some endocrine or metabolic markers measured in the postacute phase of critical illness might have a prognostic value.

Original languageEnglish (US)
Article numberR47
JournalCritical Care
Issue number1
StatePublished - Feb 3 2011

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Hormonal status in protracted critical illness and in-hospital mortality'. Together they form a unique fingerprint.

Cite this